Tacoba Forte 0.1% Ointment

generic_icon
Rs.397for 1 tube(s) (10 gm Ointment each)
1
Unfortunately, we don't have any more items in stock
Available in other variants
Report Error

Composition FOR Tacoba 0.1% w/w Ointment

Tacrolimus(0.1% w/w)

food interaction for Tacoba Ointment

alcohol interaction for Tacoba Ointment

pregnancy interaction for Tacoba Ointment

lactation interaction for Tacoba Ointment

medicine interaction for Tacoba Ointment

food
alcohol
pregnancy
lactation
medicine
No interaction found/established
No interaction found/established
The safety of Tacoba Forte 0.1% Ointment during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing.
CONSULT YOUR DOCTOR
Tacoba Forte 0.1% Ointment may be safe to use during breastfeeding. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
SAFE IF PRESCRIBED
No interaction found/established

SALT INFORMATION FOR Tacoba 0.1% w/w Ointment

Tacrolimus(0.1% w/w)

Tacoba ointment uses

{med_name} is used for Atopic dermatitis.

How tacoba ointment works

Tacoba Forte 0.1% Ointment is an immunosuppressant. It works by suppressing the activity of certain immune cells that cause inflammation (redness and swelling) of the skin. This relieves itching and improves rashes in atopic dermatitis.

Common side effects of tacoba ointment

Headache, Hair follicle inflammation, Application site reactions (burning, irritation, itching and redness)

SUBSTITUTES FOR Tacoba Ointment

144 Substitutes
144 Substitutes
Sorted By
RelevancePrice
  • Hhmus 0.1% XL Ointment
    (30 gm Ointment in tube)
    Rs. 25/gm of Ointment
    generic_icon
    Rs. 750
    save 37% more per gm of Ointment
  • Tacroz Forte Ointment
    (10 gm Ointment in tube)
    Rs. 51.10/gm of Ointment
    generic_icon
    Rs. 515.60
    pay 29% more per gm of Ointment
  • Tacroz Forte Ointment
    (20 gm Ointment in tube)
    Rs. 38/gm of Ointment
    generic_icon
    Rs. 782.80
    save 4% more per gm of Ointment
  • Tbis 0.1% Ointment
    (10 gm Ointment in tube)
    Rs. 57.90/gm of Ointment
    generic_icon
    Rs. 579
    pay 46% more per gm of Ointment
  • Takfa Forte Ointment
    (10 gm Ointment in tube)
    Rs. 38.40/gm of Ointment
    generic_icon
    Rs. 384.38
    save 3% more per gm of Ointment

Expert advice FOR Tacoba Ointment

  • Tacrolimus is effective at treating eczema (atopic dermatitis) when other treatment options have failed.
  • It works by decreasing itching, redness, and skin rashes.
  • Apply thinly, to affected areas of skin only. Clean the affected area and dry well before applying Tacrolimus. Avoid contact with water after application.
  • Inform your doctor if there's no improvement even after two weeks of treatment, or if the skin gets worse.
  • Don't cover the area being treated with airtight dressings such as bandages unless directed by a doctor, as this may increase the risk of side effects.
  • Stop using Tacrolimus and consult your doctor if your eczema becomes infected.
  • Continuous long-term use of the ointment should be avoided. Use as prescribed by you doctor.

Frequently asked questions FOR Tacoba 0.1% w/w Ointment

Tacrolimus

Q. What is Tacoba Forte 0.1% Ointment used for?
Tacoba Forte 0.1% Ointment is a medicine that modulates the immune system. It works on the immune system and mostly decreases its activity. It is used to treat moderate to severe eczema (atopic dermatitis) in adults who do not respond to steroids or develop side effects on using them. In atopic dermatitis, the skin’s immune system undergoes an overreaction and causes skin inflammation leading to itchiness, redness and dryness. Tacoba Forte 0.1% Ointment acts on the abnormal immune response and alters it, thereby relieving the skin inflammation and itchiness.
Q. What are the side effects of Tacoba Forte 0.1% Ointment?
Tacoba Forte 0.1% Ointment, when applied to the skin, may cause skin irritation, burning sensation and itching at the site of application. These are usually mild to moderate in severity and normally resolve within one week of starting the treatment. Redness is also a common manifestation along with sensation of warmth, pain, altered sensation and rash at the site of application. Using it increases the patients’ increased risk of getting inflamed or infected hair follicles, cold sores, acne and generalized herpes simplex infections.
Q. Is Tacoba Forte 0.1% Ointment ointment safe?
As compared to other immune-suppressing medicines, Tacoba Forte 0.1% Ointment has been found to be a safe and effective short-term treatment for atopic dermatitis. When applied on the affected part of the skin, its absorption to the blood and body is minimal. Hence, the side effects are less as compared to when taken through oral route.
Show More
Q. Does Tacoba Forte 0.1% Ointment has abuse potential?
No, Tacoba Forte 0.1% Ointment does not have abuse potential and thus, is not a controlled substance. Controlled substances have potential for abuse so they need permission by authorities and doctor for use.
Q. Does Tacoba Forte 0.1% Ointment cause cancer?
Long-term use of Tacoba Forte 0.1% Ointment has been found to have increased risk of lymph node tumors called lymphoma. Some studies have found that few patients who used Tacoba Forte 0.1% Ointment ointment or another similar medication developed skin cancer or lymphoma. Consult your doctor if you have to use Tacoba Forte 0.1% Ointment ointment for more than 6 weeks or if your eczema symptoms have not improved or are getting worse with time during your treatment.
Q. Is Tacoba Forte 0.1% Ointment a steroid?
No, Tacoba Forte 0.1% Ointment is not a steroid. It is a medicine which modulates the working of the immune system. It is used in the treatment of eczema, most commonly in atopic dermatitis. An advantage of Tacoba Forte 0.1% Ointment is that it does not cause skin thinning (atrophy) or other steroid-related side effects.

Content on this page was last updated on 09 December, 2025, by Dr. Rajeev Sharma (MBA, MBBS)